Atreaus Capital Takes Hedge360 for Integrated Risk Management

Atraeus, founded in 2012, has an emphasis on foreign exchange and commodities trading—via both OTC derivatives and futures—and requires reporting on value at risk (VaR), sensitivity and exposure limits, for which SunGard will provide data mapping, data validation and exception management, report generation and analytical result validation as part of the Hedge360 service. The move expands the provider's existing relationship with the fund, which already uses its Front Arena platform.
“Following implementation of the project we are already benefitting from SunGard’s in-depth risk expertise and are able to dedicate time to managing risk, rather than managing data, processes and infrastructure," says Atreaus COO Andrew Downes. "The managed service provides engineered market data and allows us to grow our reporting capabilities with ease. The interactive web dashboards provide an easy-to-use visual interface for analyzing and attributing risk using a broad range of risk metrics including VaR, sensitivities and exposures.”
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Trading Tech
Bloomberg integrates AI summaries into Port
One buy-side user says that while it’s still early for agentic tools, they’re excited by what they’ve seen so far.
Larry Fink: ‘We need to be tokenizing all assets’
The asset manager is currently exploring tokenizing long-term investment products like iShares, with an eye on non-financial assets down the road.
Examining how adaptive intelligence can create resilient trading ecosystems
Researchers from IBM and Wipro explore how multi-agent LLMs and multi-modal trading agents can be used to build trading ecosystems that perform better under stress.
S&P Global partners with IBM, Eventus launches Frank AI, Tradeweb expands algo execution abilities, and more
The Waters Cooler: Arcesium makes waves with Aquata Marketplace, NYSE Cloud flows into Blue Ocean Technologies, and more in this week’s news roundup.
Robinhood looks to ‘Chaos Monkey’ for op resilience playbook
As firms look to break down silos across business divisions to bolster operational resilience, the US broker is ditching emails, while utilizing chaos engineering and automating everything in sight.
Bank of America’s GenAI plan wants to avoid ‘sins of the past’
Waters Wrap: Anthony spoke with BofA’s head of platform and head of technology to discuss how the bank is exploring new forms of AI while reducing tech debt and growing interoperability.
TMX Group buys Verity, Deutsche Börse puts market data on-chain, and more
The Waters Cooler: The Texas Stock Exchange is SEC-approved, FalconX launches 24/7 access to OTC crypto options, and the CFTC needs a chair.
WatersTechnology latest edition
Check out our latest edition, plus more than 13 years of our best content.